Ana Podolski-Renić

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Venues

Cancers

Diagnostics (Basel, Switzerland)

Brain sciences

Plants (Basel, Switzerland)

University of Belgrade Faculty of Biology (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Belgrade Faculty of Biology

Serbia

PHD :: Molecular Biology

Publications

Jelena Dinic, Miodrag Dragoj, Sofija Jovanović Stojanov, Ana Stepanović, Ema Lupšić, Milica Pajović, Thomas Mohr, Sofija Glumac, Dragana Marić, Maja Ercegovac, Ana Podolski-Renić, Milica Pesic
Multidrug-Resistant Profiles in Non-Small Cell Lung Carcinoma Patient-Derived Cells: Implications for Personalized Approaches with Tyrosine Kinase Inhibitors. Cancers 16 (11) (2024)
Jelena Dinic, Miodrag Dragoj, Sofija Jovanović Stojanov, Ana Stepanović, Ema Lupšić, Milica Pajović, Thomas Mohr, Sofija Glumac, Dragana Marić, Maja Ercegovac, Ana Podolski-Renić, Milica Pesic
Multidrug-Resistant Profiles in Non-Small Cell Lung Carcinoma Patient-Derived Cells: Implications for Personalized Approaches with Tyrosine Kinase Inhibitors. Cancers 16 (11) (2024)
Milka Jadranin, Danica Savić, Ema Lupšić, Ana Podolski-Renić, Milica Pesic, Vele Tešević, Slobodan Milosavljević, Gordana Krstić
LC-ESI QToF MS Non-Targeted Screening of Latex Extracts of Euphorbia seguieriana ssp. seguieriana Necker and Euphorbia cyparissias and Determination of Their Potential Anticancer Activity. Plants (Basel, Switzerland) 12 (24) (2023)
Sofija Jovanović Stojanov, Epole N Ntungwe, Jelena Dinic, Ana Podolski-Renić, Milica Pajović, Patrícia Ríjo, Milica Pesic
Coleon U, Isolated from Plectranthus mutabilis Codd., Decreases P-Glycoprotein Activity Due to Mitochondrial Inhibition. Pharmaceutics 15 (7) (2023)
Jelena Dinic, Ana Podolski-Renić, Miodrag Dragoj, Sofija Jovanović Stojanov, Ana Stepanović, Ema Lupšić, Milica Pajović, Mirna Jovanović, Dušica Petrović Rodić, Dragana Marić, Maja Ercegovac, Milica Pesic
Immunofluorescence-Based Assay for High-Throughput Analysis of Multidrug Resistance Markers in Non-Small Cell Lung Carcinoma Patient-Derived Cells. Diagnostics (Basel, Switzerland) 13 (24) (2023)
Jelena Dinic, Ana Podolski-Renić, Miodrag Dragoj, Sofija Jovanović Stojanov, Ana Stepanović, Ema Lupšić, Milica Pajović, Mirna Jovanović, Dušica Petrović Rodić, Dragana Marić, Maja Ercegovac, Milica Pesic
Immunofluorescence-Based Assay for High-Throughput Analysis of Multidrug Resistance Markers in Non-Small Cell Lung Carcinoma Patient-Derived Cells. Diagnostics (Basel, Switzerland) 13 (24) (2023)
Jelena Dinic, Ana Podolski-Renić, Miodrag Dragoj, Sofija Jovanović Stojanov, Ana Stepanović, Ema Lupšić, Milica Pajović, Mirna Jovanović, Dušica Petrović Rodić, Dragana Marić, Maja Ercegovac, Milica Pesic
Immunofluorescence-Based Assay for High-Throughput Analysis of Multidrug Resistance Markers in Non-Small Cell Lung Carcinoma Patient-Derived Cells. Diagnostics (Basel, Switzerland) 13 (24) (2023)
Milka Jadranin, Danica Savić, Ema Lupšić, Ana Podolski-Renić, Milica Pesic, Vele Tešević, Slobodan Milosavljević, Gordana Krstić
LC-ESI QToF MS Non-Targeted Screening of Latex Extracts of Euphorbia seguieriana ssp. seguieriana Necker and Euphorbia cyparissias and Determination of Their Potential Anticancer Activity. Plants (Basel, Switzerland) 12 (24) (2023)
Ana Podolski-Renić, Jelena Dinic, Tijana Stanković, Ivanka Tsakovska, Ilza Pajeva, Tiziano Tuccinardi, Lorenzo Botta, Silvia Schenone, Milica Pesic
New Therapeutic Strategy for Overcoming Multidrug Resistance in Cancer Cells with Pyrazolo[3,4-d]pyrimidine Tyrosine Kinase Inhibitors. Cancers 13 (21) (2021)
Ana Kostić, Sofija Jovanović Stojanov, Ana Podolski-Renić, Marija Stepanović, Miodrag Dragoj, Igor Nikolić, Goran Tasić, Silvia Schenone, Milica Pesic, Jelena Dinic
Pyrazolo[3,4-d]pyrimidine Tyrosine Kinase Inhibitors Induce Oxidative Stress in Patient-Derived Glioblastoma Cells. Brain sciences 11 (7) (2021)
Miodrag Dragoj, Jasmina Stojkovska, Tijana Stanković, Jelena Dinic, Ana Podolski-Renić, Bojana Obradović, Milica Pesic
Development and Validation of a Long-Term 3D Glioblastoma Cell Culture in Alginate Microfibers as a Novel Bio-Mimicking Model System for Preclinical Drug Testing. Brain sciences 11 (8) (2021)
Petar Stupar, Ana Podolski-Renić, Maria Ines Villalba, Miodrag Dragoj, Sofija Jovanović Stojanov, Milica Pesic, Sandor Kasas
Nano-Motion Analysis for Rapid and Label Free Assessing of Cancer Cell Sensitivity to Chemotherapeutics. Medicina (Kaunas, Lithuania) 57 (5) (2021)
Ahmed Dhahir Latif, Tamás Jernei, Ana Podolski-Renić, Ching-Ying Kuo, Máté Vágvölgyi, Gábor Girst, István Zupkó, Sedef Develi, Engin Ulukaya, Hui-Chun Wang, Milica Pesic, Antal Csámpai, Attila Hunyadi
Protoflavone-Chalcone Hybrids Exhibit Enhanced Antitumor Action through Modulating Redox Balance, Depolarizing the Mitochondrial Membrane, and Inhibiting ATR-Dependent Signaling. Antioxidants (Basel, Switzerland) 9 (6) (2020)
Marija Stepanović, Aleksandra Divac Rankov, Ana Podolski-Renić, Igor Nikolić, Goran Tasić, Arianna Mancini, Silvia Schenone, Milica Pesic, Jelena Dinic
Src Inhibitors Pyrazolo[3,4-d]pyrimidines, Si306 and Pro-Si306, Inhibit Focal Adhesion Kinase and Suppress Human Glioblastoma Invasion In Vitro and In Vivo. Cancers 12 (6) (2020)

Ana Podolski-Renić.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ana Podolski-Renić